| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 05/16/2002 | DE10053795A1 5-HT6 Receptor antagonist medicaments, useful for treating central nervous system disorders such as Alzheimer's disease, comprising naphthalene N-phenylsulfonamide derivatives |
| 05/15/2002 | EP1204626A1 Ether compounds, compositions, and uses thereof |
| 05/15/2002 | CN1349525A Di-aryl acid derivatives as PPAR receptor ligands |
| 05/15/2002 | CN1349502A Method for the prepn. of tricyclic amino alcohol derivatives through azides |
| 05/15/2002 | CN1349501A Novel method for mfg. tricyclic amino alcohol derivatives |
| 05/15/2002 | CN1349498A Alkenyl-and alkynyl-containing metalloprotease inhibitors |
| 05/15/2002 | CN1349497A Monofluoroalkyl derivatives |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349485A 糖皮质激素受体调制剂 Glucocorticoid receptor modulators |
| 05/15/2002 | CN1349381A Sulfonamide derivatives |
| 05/15/2002 | CN1084737C Substituted sulphonyl amino (thio) caronyl compounds and their use as herbicides |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/14/2002 | US6388131 Benzenesulfonamide compounds, which encompasses the compound batabulin (2-Fluoro-1-methoxy-4-pentafluorophenylsulfonamidobenzene) |
| 05/14/2002 | US6388130 Method for producing axial asymmetric compounds, and intermediates for producing the same |
| 05/14/2002 | US6388122 Tryptase inhibitor and novel guanidino derivatives |
| 05/14/2002 | US6388094 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 05/14/2002 | US6388022 Polystyrene |
| 05/14/2002 | US6387954 Alkenyl sulphonamide derivatives |
| 05/14/2002 | US6387895 Bone disorders; cardiovascular disorders |
| 05/14/2002 | CA2105067C Indan derivative and thromboxane antagonist containing the same |
| 05/10/2002 | WO2002036556A2 Acylaminoalkyl-substituted benzenesulfonamide derivatives |
| 05/10/2002 | WO2002036555A1 Sulfamides as gamma-secretase inhibitors |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/09/2002 | US20020055616 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors |
| 05/09/2002 | US20020055046 Electrolyte composition and electrochemical battery using the same |
| 05/08/2002 | EP1202986A1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders |
| 05/08/2002 | EP1202961A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 05/08/2002 | EP1202729A1 Phosphate transport inhibitors |
| 05/08/2002 | EP1202724A2 Method for treating chronic pain using mek inhibitors |
| 05/08/2002 | EP0804464B1 Aromatic heterocyclic derivatives as enzyme inhibitors |
| 05/08/2002 | DE10054481A1 Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Acylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical compositions containing them |
| 05/08/2002 | DE10053796A1 Aminonaphthalene N-phenylsulfonamide derivatives, useful for treating central nervous system disorders, e.g. Alzheimer's disease, dementia, Parkinson's disease, are 5-HT6 receptor antagonists |
| 05/08/2002 | CN1348442A Novel sulfonamide compounds and uses thereof |
| 05/08/2002 | CN1348441A N-substituted arylsulfonyl-lamino hydroxamic acids |
| 05/08/2002 | CN1347693A Noval compound, its synthetizing process and therapeutic use |
| 05/07/2002 | US6384234 Halogenation |
| 05/07/2002 | US6384167 Mechanical properties along with a desirable level of ionic conductivity; ion-exchange membranes |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/07/2002 | US6384036 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 05/07/2002 | CA2052263C Herbicides |
| 05/02/2002 | WO2002034722A1 Imidazolium salts and their use of these ionic liquids as a solvent |
| 05/02/2002 | WO2001096283A3 Hiv integrase inhibitors |
| 05/02/2002 | WO2001064642A3 Benzamides and related inhibitors of factor xa |
| 05/02/2002 | US20020052530 Such as 3-(N-1-indanylamino)-indan-1-one 3-(N-1-indanylamino) indan-1-one formed by reacting amino-indane compound with bromo-indanone compound in presence of triethyleneamine |
| 05/02/2002 | US20020052512 Diaminopropionic acid derivatives |
| 05/02/2002 | US20020052417 Factor VIIa inhibitory (thio)urea derivatives, their preparation and their use |
| 05/02/2002 | US20020052399 In particular as inhibitors of HIV protease. |
| 05/02/2002 | US20020052395 Treatment or prevention of a disorder in which the regulation of monoamine transporter function is implicated, such as premature ejaculation. |
| 05/02/2002 | US20020052370 Including the treatment of female sexual dysfunction especially female sexual arousal disorder |
| 05/02/2002 | US20020052348 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 05/02/2002 | EP1201657A1 Imidazolium salts and the use of these ionic liquids as a solvent and as a catalyst |
| 05/02/2002 | EP1201650A2 Ionic malonitril derivatives and their uses |
| 05/02/2002 | EP1201238A1 Sulfonamide derivatives and remedies for allodynia |
| 05/02/2002 | EP1200397A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments |
| 05/02/2002 | EP1200396A1 Naphthylsulfonic acids and related compounds as glucose uptake agonists |
| 05/02/2002 | EP1200395A1 Urea derivatives as inhibitors of ccr-3 receptor |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1083831C Novel tricyclic compounds and drug compositions contg. same |
| 04/30/2002 | US6380429 Oxidation of sulfonamide |
| 04/30/2002 | US6380392 Complexes |
| 04/30/2002 | US6380358 Guanidinylation reagents |
| 04/30/2002 | US6380224 For therapy of eating disorders, obesity, bulimia nervosa, diabetes, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders, depression and anxiety |
| 04/30/2002 | US6380223 For therapy of diseases, such as obesity, diabetes, inflammation |
| 04/30/2002 | US6380219 For therapy of arthritis, cancer, tissue ulceration, restenosis, peridontal disease, epidermolysis bullosa, scleritis and other diseases characterized by matrix metalloproteinase activity, sepsis, septic shock |
| 04/30/2002 | US6380188 For inhibiting human immunodeficiency virus protease |
| 04/25/2002 | WO2002032864A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | WO2002032859A1 Process for preparation of optically active sulfonamides and intermediates for their synthesis |
| 04/25/2002 | WO2002032858A1 Cycloalkylfluorosulfonamide derivatives |
| 04/25/2002 | WO2002032389A1 Method of treating stroke |
| 04/25/2002 | US20020049343 Monomers do not require catalysts or long exposure to high temperatures to crosslink fluoroelastomers; fluoropolymers have enhanced adhesion to substrates |
| 04/25/2002 | US20020049236 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
| 04/25/2002 | US20020049226 Treating obesity, hyperlipidemia, glaucoma, arrhythmia, skin disorders, thyroid disease, hypothyroidism, diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis |
| 04/25/2002 | US20020049201 Sulfonamide inhibitors of aspartyl protease |
| 04/25/2002 | DE10050723A1 New N-substituted amino acid derivatives for treating thromboembolic diseases e.g. thrombosis, myocardial infarct, arteriosclerosis, inflammation, stroke, angina, restenosis are factor Xa inhibitors |
| 04/25/2002 | CA2423933A1 Pharmaceutically active sulfanilide derivatives |
| 04/25/2002 | CA2421597A1 Cycloalkylfluorosulfonamide derivatives |
| 04/25/2002 | CA2420994A1 Method of treating stroke |
| 04/24/2002 | EP1198231A1 Bicyclic antagonists selective for the(alpha)v(beta)3 integrin |
| 04/23/2002 | US6376546 Biphenyl-5-alkanoic acid derivatives and use thereof |
| 04/23/2002 | US6376538 Antiinflammatory agents; autoimmune diseases |
| 04/23/2002 | US6376534 Guanidine compound; side effect reduction |
| 04/23/2002 | US6376515 Benzamides and related inhibitors of factor Xa |
| 04/23/2002 | US6376502 Osteoporosis compounds |
| 04/18/2002 | WO2002030929A1 Novel pleuromutilin derivatives |
| 04/18/2002 | WO2002030915A2 Aryl-indane compounds for use as inhibitors of p-glycoprotein mediated transport |
| 04/18/2002 | WO2002030881A1 Sulfonylguanidine |
| 04/18/2002 | WO2002030880A2 N-substituted amino acid derivatives (factor xa inhibitors) |
| 04/18/2002 | WO2002030879A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 04/18/2002 | WO2002008177A8 N-substituted-1-amino-1,1-dialkylcarboxylic acid derivatives |
| 04/18/2002 | WO2002003995A3 Treatment of male sexual dysfunction |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | US20020045777 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes. |
| 04/18/2002 | US20020045751 Thyromimetic organic compounds |
| 04/18/2002 | US20020045749 Antibacterial agents |
| 04/18/2002 | US20020045713 Substantially fluorinated ionomers |
| 04/18/2002 | US20020045644 2-phenylpyran-4-one derivatives |
| 04/18/2002 | US20020045231 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 04/18/2002 | DE10048716A1 Use of sulfonylguanidine derivatives, mostly new compounds, for treating e.g. pain and neurodegeneration, have affinity for the gabapentin binding site |
| 04/18/2002 | CA2765409A1 Hydroxamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |